APO Research
Talk to an analyst

APO RESEARCH · REPORT

Preventive Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Preventive Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025188 pages

Choose your research edition.

Industry ResearchPreventive Vaccines Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Preventive Vaccines Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Preventive Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preventive Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Preventive Vaccines Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Preventive Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Preventive Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Preventive Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preventive Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Preventive Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Preventive Vaccines include Abbott, Sanofi, GlaxoSmithKline, AstraZeneca, Serum Institute of India and CSL Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Preventive Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Preventive Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Preventive Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Preventive Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Preventive Vaccines Segment by Company

Abbott

Sanofi

GlaxoSmithKline

AstraZeneca

Serum Institute of India

CSL Ltd

Preventive Vaccines Segment by Type

Intradermal Shot

Intramuscular Injection

Nasal Spray

Preventive Vaccines Segment by Application

Hospital

Clinic

Other

Preventive Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preventive Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preventive Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preventive Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Preventive Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Preventive Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Preventive Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Preventive Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Preventive Vaccines Industry Trends Table 2. Preventive Vaccines Industry Drivers Table 3. Preventive Vaccines Industry Opportunities and Challenges Table 4. Preventive Vaccines Industry Restraints Table 5. Global Preventive Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Preventive Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Preventive Vaccines Sales by Manufacturers (doses) & (2021-2026) Table 8. Global Preventive Vaccines Sales Market Share by Manufacturers Table 9. Global Preventive Vaccines Average Sales Price (US$/dose) of Manufacturers (2021-2026) Table 10. Global Preventive Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Preventive Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Preventive Vaccines Manufacturers, Product Type & Application Table 13. Global Preventive Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Preventive Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Intradermal Shot Table 17. Major Manufacturers of Intramuscular Injection Table 18. Major Manufacturers of Nasal Spray Table 19. Global Preventive Vaccines Sales by Type 2021 VS 2025 VS 2032 (doses) Table 20. Global Preventive Vaccines Sales by Type (2021-2026) & (doses) Table 21. Global Preventive Vaccines Sales by Type (2027-2032) & (doses) Table 22. Global Preventive Vaccines Sales Market Share by Type (2021-2026) Table 23. Global Preventive Vaccines Sales Market Share by Type (2027-2032) Table 24. Global Preventive Vaccines Revenue by Type 2021 VS 2025 VS 2032 (doses) Table 25. Global Preventive Vaccines Revenue by Type (2021-2026) & (doses) Table 26. Global Preventive Vaccines Revenue by Type (2027-2032) & (doses) Table 27. Global Preventive Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global Preventive Vaccines Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Other Table 32. Global Preventive Vaccines Sales by Application 2021 VS 2025 VS 2032 (doses) Table 33. Global Preventive Vaccines Sales by Application (2021-2026) & (doses) Table 34. Global Preventive Vaccines Sales by Application (2027-2032) & (doses) Table 35. Global Preventive Vaccines Sales Market Share by Application (2021-2026) Table 36. Global Preventive Vaccines Sales Market Share by Application (2027-2032) Table 37. Global Preventive Vaccines Revenue by Application 2021 VS 2025 VS 2032 (doses) Table 38. Global Preventive Vaccines Revenue by Application (2021-2026) & (doses) Table 39. Global Preventive Vaccines Revenue by Application (2027-2032) & (doses) Table 40. Global Preventive Vaccines Revenue Market Share by Application (2021-2026) Table 41. Global Preventive Vaccines Revenue Market Share by Application (2027-2032) Table 42. Global Preventive Vaccines Sales by Region: 2021 VS 2025 VS 2032 (doses) Table 43. Global Preventive Vaccines Sales by Region (2021-2026) & (doses) Table 44. Global Preventive Vaccines Sales Market Share by Region (2021-2026) Table 45. Global Preventive Vaccines Sales Forecasted by Region (2027-2032) & (doses) Table 46. Global Preventive Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Preventive Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (doses) Table 48. North America Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 49. North America Preventive Vaccines Sales by Country (2027-2032) & (doses) Table 50. Europe Preventive Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (doses) Table 51. Europe Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 52. Europe Preventive Vaccines Sales by Country (2027-2032) & (doses) Table 53. Asia Pacific Preventive Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (doses) Table 54. Asia Pacific Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 55. Asia Pacific Preventive Vaccines Sales by Country (2027-2032) & (doses) Table 56. South America, Middle East and Africa Preventive Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (doses) Table 57. South America, Middle East and Africa Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 58. South America, Middle East and Africa Preventive Vaccines Sales by Country (2027-2032) & (doses) Table 59. Global Preventive Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Preventive Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Preventive Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Preventive Vaccines Revenue Market Share by Region (2021-2026) Table 63. Global Preventive Vaccines Revenue Market Share by Region (2027-2032) Table 64. Abbott Company Information Table 65. Abbott Business Overview Table 66. Abbott Preventive Vaccines Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Abbott Preventive Vaccines Product Portfolio Table 68. Abbott Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Preventive Vaccines Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sanofi Preventive Vaccines Product Portfolio Table 73. Sanofi Recent Development Table 74. GlaxoSmithKline Company Information Table 75. GlaxoSmithKline Business Overview Table 76. GlaxoSmithKline Preventive Vaccines Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. GlaxoSmithKline Preventive Vaccines Product Portfolio Table 78. GlaxoSmithKline Recent Development Table 79. AstraZeneca Company Information Table 80. AstraZeneca Business Overview Table 81. AstraZeneca Preventive Vaccines Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. AstraZeneca Preventive Vaccines Product Portfolio Table 83. AstraZeneca Recent Development Table 84. Serum Institute of India Company Information Table 85. Serum Institute of India Business Overview Table 86. Serum Institute of India Preventive Vaccines Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Serum Institute of India Preventive Vaccines Product Portfolio Table 88. Serum Institute of India Recent Development Table 89. CSL Ltd Company Information Table 90. CSL Ltd Business Overview Table 91. CSL Ltd Preventive Vaccines Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. CSL Ltd Preventive Vaccines Product Portfolio Table 93. CSL Ltd Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Preventive Vaccines Distributors List Table 97. Preventive Vaccines Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Preventive Vaccines Product Image Figure 2. Global Preventive Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Preventive Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Preventive Vaccines Sales (2021-2032) & (doses) Figure 5. Global Preventive Vaccines Average Price (US$/dose) & (2021-2032) Figure 6. Global Top 5 and 10 Preventive Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Intradermal Shot Image Figure 9. Intramuscular Injection Image Figure 10. Nasal Spray Image Figure 11. Global Preventive Vaccines Sales by Type (2021 VS 2025 VS 2032) & (doses) Figure 12. Global Preventive Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Preventive Vaccines Sales Market Share by Type (2021-2032) Figure 14. Global Preventive Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (doses) Figure 15. Global Preventive Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Preventive Vaccines Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Preventive Vaccines Sales by Application (2021 VS 2025 VS 2032) & (doses) Figure 21. Global Preventive Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Preventive Vaccines Sales Market Share by Application (2021-2032) Figure 23. Global Preventive Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (doses) Figure 24. Global Preventive Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Preventive Vaccines Revenue Market Share by Application (2021-2032) Figure 26. North America Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 27. North America Preventive Vaccines Sales Market Share by Country (2021-2032) Figure 28. U.S. Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 29. Canada Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 30. Mexico Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 31. Europe Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 32. Europe Preventive Vaccines Sales Market Share by Country (2021-2032) Figure 33. Germany Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 34. France Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 35. U.K. Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 36. Italy Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 37. Netherlands Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 38. Asia Pacific Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 39. Asia Pacific Preventive Vaccines Sales Market Share by Country (2021-2032) Figure 40. China Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 41. Japan Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 42. South Korea Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 43. Southeast Asia Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 44. India Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 45. Australia Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 46. South America, Middle East and Africa Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 47. South America, Middle East and Africa Preventive Vaccines Sales Market Share by Country (2021-2032) Figure 48. Brazil Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 49. South Africa Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 50. Saudi Arabia Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 51. Turkey Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 52. Argentina Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 53. UAE Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 54. Egypt Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 55. Chile Preventive Vaccines Sales and Growth Rate (2021-2032) & (doses) Figure 56. Global Preventive Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Preventive Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Preventive Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. North America Preventive Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Preventive Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Europe Preventive Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Preventive Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Preventive Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Preventive Vaccines Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Preventive Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Preventive Vaccines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Preventive Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Intradermal Shot
  • Intramuscular Injection
  • Nasal Spray
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Abbott
  • Sanofi
  • GlaxoSmithKline
  • AstraZeneca
  • Serum Institute of India
  • CSL Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Preventive Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Preventive Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Preventive Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Preventive Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Preventive Vaccines Market Dynamics
  1. 2.1 Preventive Vaccines Industry Trends
  2. 2.2 Preventive Vaccines Industry Drivers
  3. 2.3 Preventive Vaccines Industry Opportunities and Challenges
  4. 2.4 Preventive Vaccines Industry Restraints
3 Preventive Vaccines Market by Manufacturers
  1. 3.1 Global Preventive Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Preventive Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Preventive Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Preventive Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Preventive Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Preventive Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Preventive Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Preventive Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Preventive Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Preventive Vaccines Tier 1, Tier 2, and Tier 3
4 Preventive Vaccines Market by Type
  1. 4.1 Preventive Vaccines Type Introduction
  2. 4.1.1 Intradermal Shot
  3. 4.1.2 Intramuscular Injection
  4. 4.1.3 Nasal Spray
  5. 4.2 Global Preventive Vaccines Sales by Type
  6. 4.2.1 Global Preventive Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Preventive Vaccines Sales by Type (2021-2032)
  8. 4.2.3 Global Preventive Vaccines Sales Market Share by Type (2021-2032)
  9. 4.3 Global Preventive Vaccines Revenue by Type
  10. 4.3.1 Global Preventive Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Preventive Vaccines Revenue by Type (2021-2032)
  12. 4.3.3 Global Preventive Vaccines Revenue Market Share by Type (2021-2032)
5 Preventive Vaccines Market by Application
  1. 5.1 Preventive Vaccines Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Preventive Vaccines Sales by Application
  6. 5.2.1 Global Preventive Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Preventive Vaccines Sales by Application (2021-2032)
  8. 5.2.3 Global Preventive Vaccines Sales Market Share by Application (2021-2032)
  9. 5.3 Global Preventive Vaccines Revenue by Application
  10. 5.3.1 Global Preventive Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Preventive Vaccines Revenue by Application (2021-2032)
  12. 5.3.3 Global Preventive Vaccines Revenue Market Share by Application (2021-2032)
6 Global Preventive Vaccines Sales by Region
  1. 6.1 Global Preventive Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Preventive Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Preventive Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Preventive Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Preventive Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Preventive Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Preventive Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Preventive Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Preventive Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Preventive Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Preventive Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Preventive Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Preventive Vaccines Revenue by Region
  1. 7.1 Global Preventive Vaccines Revenue by Region
  2. 7.1.1 Global Preventive Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Preventive Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Preventive Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Preventive Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Preventive Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Preventive Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Preventive Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Preventive Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Preventive Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Preventive Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Preventive Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Preventive Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Preventive Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Preventive Vaccines Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Preventive Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Preventive Vaccines Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Preventive Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Preventive Vaccines Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Preventive Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Preventive Vaccines Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Serum Institute of India
  26. 8.5.1 Serum Institute of India Company Information
  27. 8.5.2 Serum Institute of India Business Overview
  28. 8.5.3 Serum Institute of India Preventive Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Serum Institute of India Preventive Vaccines Product Portfolio
  30. 8.5.5 Serum Institute of India Recent Developments
  31. 8.6 CSL Ltd
  32. 8.6.1 CSL Ltd Company Information
  33. 8.6.2 CSL Ltd Business Overview
  34. 8.6.3 CSL Ltd Preventive Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CSL Ltd Preventive Vaccines Product Portfolio
  36. 8.6.5 CSL Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Preventive Vaccines Value Chain Analysis
  2. 9.1.1 Preventive Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Preventive Vaccines Production Mode & Process
  6. 9.2 Preventive Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Preventive Vaccines Distributors
  9. 9.2.3 Preventive Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst